Detecting sedation and analgesia withdrawal symptoms in patients in intensive care units
Intensive Care Unit
What is the research about?
Intensive care patients receiving more than 72-hours of infusions of sedatives and analgesics are at risk of developing withdrawal symptoms when the infusions are reduced and stopped. Currently, in adult intensive care, there are no screening checklists.
Our research seeks to develop a screening checklist for staff to detect early when a patient starts to display these symptoms so that appropriate action can be taken. Our methods will involve interviewing patients, carers and staff to develop a checklist prototype and then test its ability to correctly detect withdrawal.
We are currently developing a proposal for a PhD and are looking for people who have been a patient in ICU or have had a family member/close friend who has been in ICU to help us develop the proposal.
Involvement Opportunity Details
3 x 1-hour meetings
Contact between meetings:
Length of involvement:
Start date for involvement:
If online, explain how:
MS Teams or Zoom
If in person, explain where:
Other ways of communicating:
Funding available for:
If no funding available, explain why:
Stage of the research study/ programme:
Is this opportunity for PPI in a PhD:
Closing date to contact researchers:
Queen's University Belfast
Pharmacist, Addiction Specialist, Psychologist, Doctor, Nurse
HSC PHA R&D
Interested in this PPI Opportunity?
Please complete this form and click SUBMIT